Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Banner MD Anderson Cancer Center, Gilbert, AZ

2 abstracts

Abstract
The initial report of phase I trial of VG2025, a non-attenuated HSV-1 oncolytic virus expressing IL-12 and IL-15/RA payloads, in patients with advanced solid tumors.
Org: Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, Banner MD Anderson Cancer Center, Gilbert, AZ, Virogin Biotech, Jonesville, FL, Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, Virogin Biotech (Shanghai) Ltd, Shanghai, China,
Abstract
Risk reduction of CNS relapse in diffuse large B cell lymphoma with intrathecal methotrexate prophylaxis: A single institution retrospective study.
Org: Department of Internal Medicine, Loma Linda University Medical Center, Loma Linda, CA, Banner MD Anderson Cancer Center, Gilbert, AZ, Department of Oncology/Hematology, Loma Linda University Medical Center, Loma Linda, CA,